Close

Dynavax (DVAX) Receives DSMB Recommendation to Continue HEPLISAV-B Phase 3

March 2, 2015 7:49 AM EST Send to a Friend
Dynavax (NASDAQ: DVAX) announced that the independent Data and Safety Monitoring Board (DSMB) charged with periodically reviewing safety data from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login